News

Name Your NET Hero for NET Cancer Day

Everyone has a hero – a person whose support, faith and positive energy are crucial in one’s journey through life. We all need a shoulder to lean on.
 

Name Your NET Hero to mark Worldwide NET Cancer Awareness Day, November …

Coming Soon — New Feature on Find a Doctor List

The Carcinoid Cancer Foundation welcomes feedback from the carcinoid/NET community so that we can regularly update our website, providing the most sought-after and up-to-date information possible.  Recently we were asked to add a feature to our Find…

Nutrition and Neuroendocrine Tumors

What is a healthy diet for neuroendocrine tumor patients? If a NET patient has carcinoid syndrome which foods should be avoided? Are supplements recommended for carcinoid/NET patients? When NET patients have problems related to malabsorption and …

A Possible Cure for Neuroendocrine Cancer: Exciting Update!

Thanks to the enormously generous gift of about $2 million from Vincent Hamilton, founder and Chairman of the Board of Tethys Oil AB and the  amazing iCancer campaign — the championing of the cause by Alexander Masters, Dominic Nutt and Liz Scarff in Europe…

Neuroendocrine Cancer: Making Sense of the Disease

With deepest appreciation to the Carcinoid Cancer Texas Survivors Support Group for sponsoring, videotaping,and giving permission to the Carcinoid Cancer Foundation to share Dr. Eric Liu’s presentation,“Neuroendocrine Cancer: …

Carcinoid/NET Specialist Dr. Eric Liu to Speak in Dallas, Texas

“Neuroendocrine Cancer: Making Sense of the Disease” is a special presentation by Dr. Eric Liu, Director of the Neuroendocrine Center at Vanderbilt University Medical Center in Nashville, Tennessee, scheduled for June 8 at Baylor Hospital,…

Carcinoid Survivor Thrives as Endurance Rider

Monica Grundmann, who was diagnosed with goblet cell carcinoid in 2012, thought she had entered her last competitive event in June 2012.  She won that OCTRA-sponsored Stormont Competitive Trail Ride, and dedicated her ride to the Carcinoid Cancer Foundation…

Neuroendocrine Tumors Featured in Society of Nuclear Medicine and Molecular Imaging Patient Program

Josh Mailman, President of the NorCal CarciNET support group and Chair of the Patient Advocate Advisory Board for the Society of Nuclear Medicine and Molecular Imaging (SNMMI), will give the Welcome presentation for the SNMMI Patient Education Day …

Carcinoid/Neuroendocrine Tumor Presentations at ASCO Annual Meeting

Twenty-six abstracts about carcinoid and other NETs will be presented at the 2013 ASCO (American Society of Clinical Oncology) Annual Meeting, to be held May 31 to June 4 in Chicago, Illinois. Cutting-edge scientific presentations and comprehensive…

Mayo Clinic Completes First Whole Exome Sequence of Small Intestine Neuroendocrine Tumors

Researchers at the Mayo Clinic in Rochester, Minnesota have completed the first whole exome sequence of small intestine neuroendocrine tumors and have identified six pathways as potential drug targets for these NETs. Read more about the Mayo Clinic…